CCRL2

Chr 3

C-C motif chemokine receptor like 2

Also known as: ACKR5, CKRX, CRAM, CRAM-A, CRAM-B, HCR

This gene encodes a chemokine receptor-like protein that binds CCL19 and chemerin but does not appear to function as a signaling receptor, instead modulating immune responses by capturing and internalizing ligands or presenting them to functional receptors. The protein plays a critical role in developing Th2 immune responses and is highly expressed in neutrophils and monocytes. No disease associations have been established for mutations in this gene.

OMIMResearchSummary from RefSeq, UniProt
MultiplemechanismLOEUF 1.78
Clinical SummaryCCRL2
Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.00) despite low pLI — interpret in context.
📋
ClinVar Variants
8 unique Pathogenic / Likely Pathogenic· 50 VUS of 66 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.78LOEUF
pLI 0.369
Z-score 0.82
OE 0.00 (0.001.78)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
-0.41Z-score
OE missense 1.08 (0.961.22)
203 obs / 187.4 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE0.00 (0.001.78)
00.351.4
Missense OE1.08 (0.961.22)
00.61.4
Synonymous OE0.98
01.21.6
LoF obs/exp: 0 / 0.8Missense obs/exp: 203 / 187.4Syn Z: 0.12
DN
0.74top 25%
GOF
0.6640th %ile
LOF
0.2679th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

66 submitted variants in ClinVar

Classification Summary

Pathogenic7
Likely Pathogenic1
VUS50
Likely Benign7
Benign1
7
Pathogenic
1
Likely Pathogenic
50
VUS
7
Likely Benign
1
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
7
0
7
Likely Pathogenic
0
0
1
0
1
VUS
0
49
1
0
50
Likely Benign
0
7
0
0
7
Benign
1
0
0
0
1
Total1569066

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

CCRL2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Full-Text Mentions
NLP-detected gene mentions in article bodies · via PubTator3
PubTator3
Top 5 full-text resultsSearch PubTator3 ↗